Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Market Cap	6.48B
Revenue (ttm)	352.91M
Net Income (ttm)	43.24M
Shares Out	113.82M
EPS (ttm)	0.37
PE Ratio	155.40
Forward PE	88.94
Dividend	0.42 (0.73%)
Ex-Dividend Date	Sep 15, 2025

Volume	904,568
Average Volume	1,581,596
Open	55.90
Previous Close	56.50
Day's Range	55.90 - 57.96
52-Week Range	31.85 - 67.80
Beta	0.74
RSI	49.22
Earnings Date	Oct 30, 2025

About Shanghai OPM Biosciences

Shanghai OPM Biosciences Co., Ltd. provides cell culture media and CDMO services in China and internationally. The company offers OPM cell culture media services, including OPM-CHO platform, OPM-293 platform, OPM-VAC platform, OPM-Hybri platform, and classical media; customized media solutions; and OEM media manufacturing services. It also provides end-to-end biologics CDMO services, such as antibody discovery, stable cell line development & cell banking platform, upstream process development, downstream process development, OPM formulation dev...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 328
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688293

Financial Performance

In 2024, Shanghai OPM Biosciences's revenue was 297.24 million, an increase of 22.26% compared to the previous year's 243.12 million. Earnings were 21.05 million, a decrease of -61.04%.